Brief: Spyre Therapeutics Announces Proposed Public Offering Of Its Common Stock
13/04/2026 22:08
April 13 (Reuters) - Spyre Therapeutics Inc SYRE.O: SPYRE THERAPEUTICS ANNOUNCES PROPOSED PUBLIC OFFERING OF ITS COMMON STOCK SPYRE THERAPEUTICS INC - COMMENCES $300 MILLION UNDERWRITTEN PUBLIC OFFERING OF COMMON STOCK Source text: ID:nGNX4ZlVGg Further company coverage: SYRE.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Spyre Therapeutics
See all newsU.S. STOCKS ON THE MOVE-Becton Dickinson, Constellation Energy, Marvell
U.S. STOCKS ON THE MOVE-Constellation Energy, AMD
U.S. STOCKS ON THE MOVE-MYR Group, Spyre Therapeutics, AMD
Spyre Therapeutics slips on $350 mln share sale
Brief: Spyre Therapeutics Announces Pricing Of $350.0 Million Public Offering Of Common Stock